Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.67 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.65 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.65 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PRF1 | P14222 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7905308 | 0.96 | APP (0.68) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL10472980 | 0.96 | APP (0.73) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL28831708 | 0.84 | APP (0.59) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL5399485 | 0.84 | APP (0.94) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL30903822 | 0.84 | APP (0.94) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL30903823 | 0.84 | APP (0.94) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL30903820 | 0.84 | APP (0.94) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL7006689 | 0.82 | APP (0.91) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL5760473 | 0.81 | CYP2E1 (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL9199395 | 0.81 | CYP2E1 (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431349-B | Mitochondrial-targeted fluorescent dye and application thereof in biological imaging and tumor treatment | 郑州大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250327191-A1 | CORROSSION INHIBITOR COMPOSITIONS | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-10-23 | — | — | US | claimed |
| EP-4636130-A1 | CORROSSION INHIBITOR COMPOSITIONS | Tata Consultancy Services Limited (IN) | 2025-10-22 | — | — | EP | claimed |
| CN-119431349-A | Mitochondrial-targeted fluorescent dye and application thereof in biological imaging and tumor treatment | 郑州大学 | 2025-02-14 | — | — | CN | claimed |
| CN-115583944-B | Preparation method and application of benzothiazole derivative | 哈尔滨理工大学 | 2024-06-21 | — | — | CN | claimed |
| CN-115583944-A | Preparation method and application of benzothiazole derivative | 哈尔滨理工大学 | 2023-01-10 | — | — | CN | claimed |
| CN-100343256-C | Biaryl substituted diazabicycloalkane amides as nicotinic acetylcholine agonists | ASTRAZENECA AB (SE) | 2007-10-17 | — | — | CN | claimed |
| CN-1678615-A | Biaryl substituted diazabicycloalkanes as nicotinic acetylcholine antagonists | ASTRAZENECA AB (SE) | 2005-10-05 | — | — | CN | claimed |
| CN-119431349-B | Mitochondrial-targeted fluorescent dye and application thereof in biological imaging and tumor treatment | 郑州大学 | 2026-02-27 | — | — | CN | disclosed |
| US-20250327191-A1 | CORROSSION INHIBITOR COMPOSITIONS | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-10-23 | — | — | US | disclosed |
| EP-4636130-A1 | CORROSSION INHIBITOR COMPOSITIONS | Tata Consultancy Services Limited (IN) | 2025-10-22 | — | — | EP | disclosed |
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-119768164-A | Pharmaceutical compounds for treating complement-mediated disorders | 阿雷克森制药公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119462585-A | Benzo-alpha-pyrone imine derivative, preparation method thereof and application of benzo-alpha-pyrone imine derivative as antifungal agent | 新疆农业大学 | 2025-02-18 | — | — | CN | disclosed |
| US-4695634-A | Hypoglycemic 5-substituted oxazolidine-2,4-diones | PFIZER INC. (US) | 1987-09-22 | — | — | US | disclosed |
| US-4622406-A | CHEMICAL INTERMEDIATES, TRIMETHYLSILOXY COMPOUNDS | PFIZER INC. (US) | 1986-11-11 | — | — | US | disclosed |
| US-4562267-A | Intermediates of hypoglycemic 5-substituted oxazolidine-2,4-diones | PFIZER INC. (US) | 1985-12-31 | — | — | US | disclosed |
| US-4423233-A | ALPHA-HYDROXY CARBOXIMIDATE INTERMEDIATES | PFIZER INC. (US) | 1983-12-27 | — | — | US | disclosed |
| US-4381308-A | Hypoglycemic 5-substituted oxazolidine-2,4-diones | PFIZER INC. (US) | 1983-04-26 | — | — | US | disclosed |
| US-4332952-A | Hypoglycemic 5-substituted oxazolidine-2,4-diones | PFIZER INC. (US) | 1982-06-01 | — | — | US | disclosed |